Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Oncology advanced practice providers should have comprehensive knowledge and competency in the area of survivorship care. This module explores the considerations and principles of comprehensive survival care of the patient with cancer.
This module explores the considerations and principles of comprehensive survivorship care of patients with cancer. Learn considerations of each treatment modality, psychosocial and spiritual impacts of treatment, best practice, and the essential influence of the advanced practice provider in care of the cancer survivor.
This module explores the considerations and principles of caring for older adults with cancer. Learn assessment tools, care modifications, pharmacologic principles, and treatment considerations specific to older adults with cancer, which will prepare advanced practice providers for the anticipated surge in survivors in this age group.
After clinical trial results demonstrated a four-month improvement in overall survival compared to best standard care, in March 2022 the U.S. Food and Drug Administration approved lutetium lu 177 vipivotide tetraxetan (PluvictoTM) to treat prostate-specific membrane antigen (PSMA)–expressing metastatic castration-resistant prostate cancer (mCRPC).
Get state-of-the-science information about how breast cancer is treated, how to manage the symptoms associated with the disease and its treatment, and nursing assessment and management of oncologic emergencies.
Initially approved in 2018, talazoparib (Talzenna®) capsules are indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene HER2-negative locally advanced or metastatic breast cancer.
The principles of antineoplastic administration require additional training and specialized knowledge, which apply in the home setting as well as healthcare facilities.